T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study

Journal of the American Society of Nephrology

Volumn 16, Issue 4, 2005, Pages 1085-1090

  Liu, Yongmei ^a   Burdon, Kathryn P ^a   Langefeld, Carl D ^a   Beck, Stephanie R ^a   Wagenknecht, Lynne E ^a   Rich, Stephen S ^a   Bowden, Donald W ^a   Freedman, Barry I ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ASPARTIC ACID; CYSTEINE; GLUTAMIC ACID; NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; THREONINE;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FAMILY STUDY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; AGED; ALBUMINURIA; EXON; GENETIC PREDISPOSITION; GENETICS; HOMOZYGOTE; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; PATHOPHYSIOLOGY; PROMOTER REGION; RISK; URINE;

AGED; ALBUMINURIA; ASPARTIC ACID; CREATININE; CYSTEINE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMIC ACID; HOMOZYGOTE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); THREONINE;

EID: 24344495518     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004100817     Document Type: Article

References (32)

1. Baylis C, Mitruka B, Deng A: Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 90: 278-281, 1992
2. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ: A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK. Circulation 100: 1515-1520, 1999
3. Lembo G, De LN, Battagli C, Iovino G, Aretini A, Musicco M, Frati G, Pompeo F, Vecchione C, Trimarco B: A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis. Stroke 32: 735-740, 2001
4. Colombo MG, Andreassi MG, Paradossi U, Botto N, Manfredi S, Masetti S, Rossi G, Clerico A, Biagini A: Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298→Asp polymorphism) to the presence, extent, and severity of coronary artery disease. Heart 87: 525-528, 2002
5. Noiri E, Satoh H, Taguchi J, Brodsky SV, Nakao A, Ogawa Y, Nishijima S, Yokomizo T, Tokunaga K, Fujita T: Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension 40: 535-540, 2002
6. Nagase S, Suzuki H, Wang Y, Kikuchi S, Hirayama A, Ueda A, Takada K, Oteki T, Obara M, Aoyagi K, Koyama A: Association of ecNOS gene polymorphisms with end stage renal diseases. Mol Cell Biochem 244: 113-118, 2003
7. Suzuki H, Nagase S, Kikuchi S, Wang Y, Koyama A: Association of a missense Glu298Asp mutation of the endothelial nitric oxide synthase gene with end stage renal disease. Clin Chem 46: 1858-1860, 2000
8. Cai H, Wilcken DE, Wang XL: The Glu-298→Asp (894G-→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease. J Mol Med 77: 511-514, 1999
9. Karvonen J, Kauma H, Kervinen K, Rantala M, Ikaheimo M, Paivansalo M, Savolainen MJ, Kesaniemi YA: Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population-based cohort. J Intern Med 251: 102-110, 2002
10. Rossi GP, Cesari M, Zanchetta M, Colonna S, Maiolino G, Pedon L, Cavallin M, Maiolino P, Pessina AC: The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study. J Am Coll Cardiol 41: 930-937, 2003
11. Schmoelzer I, Renner W, Paulweber B, Malaimare L, Iglseder B, Schmid P, Schallmoser K, Wascher TC: Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations. Eur J Clin Invest 33: 191-198, 2003
12. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS: Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 57: 405-413, 2000
13. Cai H, Wang X, Colagiuri S, Wilcken DE: A common Glu298→Asp (894G→T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes. Diabetes Care 21: 2195-2196, 1998
14. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J: Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 245: 190-193, 1998
15. Neugebauer S, Baba T, Watanabe T: Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes 49: 500-503, 2000
16. Shimizu T, Onuma T, Kawamori R, Makita Y, Tomino Y: Endothelial nitric oxide synthase gene and the development of diabetic nephropathy. Diabetes Res Clin Pract 58: 179-185, 2002
17. Rippin JD, Patel A, Belyaev ND, Gill GV, Barnett AH, Bain SC: Nitric oxide synthase gene polymorphisms and diabetic nephropathy. Diabetologia 46: 426-428, 2003
18. Asakimori Y, Yorioka N, Taniguchi Y, Ito T, Ogata S, Kyuden Y, Kohno N: T(-786)→C polymorphism of the endothelial nitric oxide synthase gene influences the progression of renal disease. Nephron 91: 747-751, 2002
19. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Ogawa H, Kugiyama K, Saito Y, Miyamoto Y, Ogawa Y, Kaneshige T, Hiramatsu H, Yoshioka T, Kamitani S, Teraoka H, Nakao K: Genetic risk factors for coronary artery spasm: Significance of endothelial nitric oxide synthase gene T-786→C and missense Glu298Asp variants. J Investig Med 48: 367-374, 2000
20. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K: T-786→C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 99: 2864-2870, 1999
21. Colombo MG, Paradossi U, Andreassi MG, Botto N, Manfredi S, Masetti S, Biagini A, Clerico A: Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 49: 389-395, 2003
22. Freedman BI, Beck SR, Rich SS, Heiss G, Lewis CE, Turner S, Province MA, Schwander KL, Arnett DK, Mellen BG: A genome-wide scan for urinary albumin excretion in hypertensive families. Hypertension 42: 291-296, 2003
23. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI: Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis 43: 796-800, 2004
24. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7: 930-937, 1996
25. Devlin B, Risch N: A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29: 311-322, 1995
26. Milliken GA, Johnson DE: Analysis of Messy Data: Vol I: Designed Experiments, Van Nostrand Reinhold, New York, 1984
27. Dudbridge F: Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25: 115-121, 2003
28. Shultz PJ, Schorer AE, Raij L: Effects of endothelium-derived relaxing factor and nitric oxide on rat mesangial cells. Am J Physiol 258: F162-F167, 1990
29. Kone BC, Baylis C: Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 272: F561-F578, 1997
30. Trachtman H, Futterweit S, Singhal P: Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 207: 120-125, 1995
31. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS: Regression of microalbuminuria in type 1 diabetes. N Engl J Med 348: 2285-2293, 2003
32. Altshuler D, Kruglyak L, Lander E: Genetic polymorphisms and disease. N Engl J Med 338: 1626, 1998